IL115293A - Method for the purification of an anti-inflammatory factor anti-inflammatory factor obtained by this method and pharmaceutical compositions containing the same - Google Patents

Method for the purification of an anti-inflammatory factor anti-inflammatory factor obtained by this method and pharmaceutical compositions containing the same

Info

Publication number
IL115293A
IL115293A IL11529395A IL11529395A IL115293A IL 115293 A IL115293 A IL 115293A IL 11529395 A IL11529395 A IL 11529395A IL 11529395 A IL11529395 A IL 11529395A IL 115293 A IL115293 A IL 115293A
Authority
IL
Israel
Prior art keywords
inflammatory factor
purification
pharmaceutical compositions
compositions containing
same
Prior art date
Application number
IL11529395A
Other languages
English (en)
Other versions
IL115293A0 (en
Original Assignee
Stole Milk Biolog Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stole Milk Biolog Inc filed Critical Stole Milk Biolog Inc
Publication of IL115293A0 publication Critical patent/IL115293A0/xx
Publication of IL115293A publication Critical patent/IL115293A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/20—Milk; Whey; Colostrum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
    • C07K2317/11—Immunoglobulins specific features characterized by their source of isolation or production isolated from eggs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Cell Biology (AREA)
  • Biomedical Technology (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Ophthalmology & Optometry (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IL11529395A 1994-10-03 1995-09-14 Method for the purification of an anti-inflammatory factor anti-inflammatory factor obtained by this method and pharmaceutical compositions containing the same IL115293A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/316,474 US5650175A (en) 1982-06-03 1994-10-03 Anti-inflammatory factor, method of isolation, and use

Publications (2)

Publication Number Publication Date
IL115293A0 IL115293A0 (en) 1995-12-31
IL115293A true IL115293A (en) 2000-12-06

Family

ID=23229212

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11529395A IL115293A (en) 1994-10-03 1995-09-14 Method for the purification of an anti-inflammatory factor anti-inflammatory factor obtained by this method and pharmaceutical compositions containing the same

Country Status (19)

Country Link
US (1) US5650175A (de)
EP (1) EP0787007B1 (de)
JP (2) JP4234197B2 (de)
KR (1) KR100424403B1 (de)
AT (1) ATE211916T1 (de)
AU (1) AU692608B2 (de)
CA (1) CA2201106C (de)
DE (1) DE69525060T2 (de)
DK (1) DK0787007T3 (de)
ES (1) ES2170809T3 (de)
FI (1) FI120574B (de)
HK (1) HK1000552A1 (de)
IL (1) IL115293A (de)
MX (1) MX9702398A (de)
NO (1) NO318921B1 (de)
NZ (2) NZ333653A (de)
PT (1) PT787007E (de)
TW (1) TW410157B (de)
WO (1) WO1996010410A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5980953A (en) * 1994-10-03 1999-11-09 Stolle Milk Biologics, Inc. Anti-inflammatory factor, method of isolation, and use
JP2001342127A (ja) * 2000-06-02 2001-12-11 Nomoto Kikuo 腸吸収性抗炎症因子含有免疫性物質及びその応用
US6770280B1 (en) 2001-11-15 2004-08-03 Humanetics Corporation Treatment of menorrhagia, hypermenorrhea, dysmenorrhea and menstrual migraines by the administration of an antibacterial milk product
US20110183052A1 (en) * 2004-10-07 2011-07-28 Next Proteins, Inc. Protein beverage and method of making the same
US20080206415A1 (en) * 2004-10-07 2008-08-28 Next Proteins, Inc. Protein beverage and method of making the same
US9220292B2 (en) 2004-10-07 2015-12-29 Next Problems, Inc. Protein beverage and method of making same
US20070025980A1 (en) * 2005-07-27 2007-02-01 Krogsgaard David L Composition permitting muscle growth while protecting joint health
US20080026983A1 (en) * 2006-07-28 2008-01-31 Gardiner Paul T Compositions and methods for alleviating joint pain and improving joint flexibility

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3128230A (en) * 1961-04-04 1964-04-07 Sunbury Milk Products Co Milk having antibodies therein and process for producing same
US3376198A (en) * 1965-07-21 1968-04-02 Collins Products Inc Method of producing antibodies in milk
GB1211876A (en) * 1967-11-23 1970-11-11 Twyford Lab Ltd Improvements in and relating to prophylactic and therapeutic preparations
CH590064A5 (de) * 1973-11-28 1977-07-29 Biokema Sa
US4324782A (en) * 1974-01-28 1982-04-13 Beck Lee R Dental caries inhibiting product of immunized cow's milk having antibodies specific to killed Streptococcus mutans cells
US4732757A (en) * 1978-02-06 1988-03-22 Stolle Research And Development Corporation Prevention and treatment of rheumatoid arthritis
US4284623A (en) * 1979-11-09 1981-08-18 Beck Lee R Method of treating inflammation using bovine milk
DE3172807D1 (en) * 1981-04-28 1985-12-12 Stolle Res & Dev Method of obtaining an anti-inflammatory bovine milk
US4897265A (en) * 1983-10-27 1990-01-30 Stolle Research & Development Corporation Method for treating disorders of the vascular and pulmonary systems
US5242691A (en) * 1982-06-03 1993-09-07 Stolle Research & Development Corporation Anti-inflammatory factor, method of isolation, and use
US4956349A (en) * 1983-10-27 1990-09-11 Stolle Research & Development Corporation Anti-inflammatory factor, method of isolation, and use
US5352462A (en) * 1982-06-03 1994-10-04 Stolle Research & Development Corporation Anti-inflammatory factor, method of isolation, and use
US4636384A (en) * 1982-06-03 1987-01-13 Stolle Research & Development Corporation Method for treating disorders of the vascular and pulmonary systems
EP0300102B1 (de) * 1987-07-21 1993-03-24 The Stolle Research And Development Corporation Verfahren zum Erhalten von immunregulierenden Faktoren mittels Säugetierimmunisierung

Also Published As

Publication number Publication date
IL115293A0 (en) 1995-12-31
DK0787007T3 (da) 2002-04-22
DE69525060D1 (de) 2002-02-21
AU3628295A (en) 1996-04-26
NZ293763A (en) 1999-02-25
FI120574B (fi) 2009-12-15
JPH10509420A (ja) 1998-09-14
ATE211916T1 (de) 2002-02-15
NZ333653A (en) 2000-08-25
NO971474L (no) 1997-06-03
JP2008133299A (ja) 2008-06-12
NO971474D0 (no) 1997-04-01
MX9702398A (es) 1997-06-28
EP0787007B1 (de) 2002-01-16
JP4234197B2 (ja) 2009-03-04
WO1996010410A1 (en) 1996-04-11
EP0787007A1 (de) 1997-08-06
US5650175A (en) 1997-07-22
HK1000552A1 (en) 2002-06-07
PT787007E (pt) 2002-07-31
TW410157B (en) 2000-11-01
NO318921B1 (no) 2005-05-23
FI971245A0 (fi) 1997-03-25
FI971245L (fi) 1997-05-28
CA2201106A1 (en) 1996-04-11
CA2201106C (en) 2010-03-23
ES2170809T3 (es) 2002-08-16
DE69525060T2 (de) 2002-11-14
KR100424403B1 (ko) 2004-05-20
KR970706008A (ko) 1997-11-03
AU692608B2 (en) 1998-06-11

Similar Documents

Publication Publication Date Title
EP2123665A3 (de) Inhibitoren des Interleukin-1$g(b) Konversionsenzyms
CA2176494A1 (en) Purification of Hemoglobin
UA29421C2 (uk) Спосіб виділення фактора vііі з інших білків в плазмі крові
CA2254871A1 (en) Purification of biologically active peptides from milk
DE69628214D1 (de) Intermediaires des produits definitifs de glycosylation avancee et inhibition des produits age post-amadori
CA2091818A1 (en) Method and apparatus for purifying islets of langerhans
MX9701183A (es) Procedimiento de preparacion del virus gripal, antigenos obtenidos y sus aplicaciones.
KR860008276A (ko) 단백질이 생성된 배양기로 부터 그것을 추출, 정제하는 방법
BG103286A (en) Compositions and methods for ore dressing
CA2093624A1 (en) Purified enzyme concentrate and method of preparation
IL115293A0 (en) An anti-inflammatory factor a method for the purification thereof and pharmaceutical compositions containing the same
IL121464A0 (en) Anti-inflammatory factor and pharmaceutical compositions containing the same
IT1266734B1 (it) Gruppo per la molatura di lastre di vetro.
ES8404514A1 (es) Procedimiento para obtener un polipeptido con efecto sobre el sistema de inmunidad
AU6415994A (en) Substituted caprolactams and derivatives thereof useful for treatment of hiv disease
FR2570278B1 (fr) Compositions et procede pour proteger les lymphocytes t contre l'agent etiologique des lymphadenopathies et du syndrome d'immunodepression acquise
HU9600209D0 (en) Process for the extaction of periplasmatic proteins from microorganisms in the presence of arginin
MY117908A (en) Anti-inflammatory factor, method of isolation, and use
EP0731709A4 (de) Neuartige neutrophile inhibitoren
GR930100408A (el) Μέ?οδος απομόνωσης και κα?αρισμού μεβινολίνης.
EP0723454A4 (de) Für die immun- und cns-therapir nutzbare, neuartige tripeptide
FI952292L (fi) Menetelmä kiinteiden materiaalien erottamiseksi mikro-organismeista
MX9805015A (es) INHIBIDORES DE LA ENZIMA QUE CONVIERTE LA INTERLEUCINA-1 beta.
GEP19960051B (en) Method for Isolation of Biologically Active Plant Peptides
AU3074000A (en) Compositions containing highly purified heparin cofactor ii and method for separating the same

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees